MDCXW Market Analysis
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -2865.0%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- -0.65
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Medicus Pharma Ltd. Warrant
Company profileMedicus Pharma Ltd. (MDCXW) is a forward-looking pharmaceutical company focused on the development and commercialization of groundbreaking therapies to meet pressing healthcare needs. With a well-defined pipeline bolstered by innovative research and strict adherence to regulatory standards, the company is adept at navigating the evolving medical landscape. Medicus Pharma is dedicated to improving patient outcomes while simultaneously creating sustainable value for its investors, positioning itself as a key player in the pharmaceutical sector.
Classification
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 300 CONSHOHOCKEN STATE ROAD, WEST CONSHOHOCKEN, PA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer